<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35971552</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-6758</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Innovation (Cambridge (Mass.))</Title><ISOAbbreviation>Innovation (Camb)</ISOAbbreviation></Journal><ArticleTitle>To manage long COVID by selective SARS-CoV-2 infection biosensing.</ArticleTitle><Pagination><StartPage>100303</StartPage><MedlinePgn>100303</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100303</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xinn.2022.100303</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaushik</LastName><ForeName>Ajeet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NanoBiotech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostafavi</LastName><ForeName>Ebrahim</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 EB009035</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Innovation (Camb)</MedlineTA><NlmUniqueID>101771342</NlmUniqueID><ISSNLinking>2666-6758</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">biosensor</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">personalized COVID-19 management</Keyword><Keyword MajorTopicYN="N">point-of-care systems</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>1</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35971552</ArticleId><ArticleId IdType="pmc">PMC9365706</ArticleId><ArticleId IdType="doi">10.1016/j.xinn.2022.100303</ArticleId><ArticleId IdType="pii">S2666-6758(22)00099-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci. Transl. Med. 2022:eabq3059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., et al. The Lancet Digital Health; 2022. Identifying Who Has Long COVID in the USA: A Machine Learning Approach Using N3C Data.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi E., Dubey A.K., Teodori L., et al. SARS-CoV-2 Omicron variant: a next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine. MedComm. 2022;3:e119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906459</ArticleId><ArticleId IdType="pubmed">35281784</ArticleId></ArticleIdList></Reference><Reference><Citation>de Puig H., Lee R.A., Najjar D., et al. Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Sci. Adv. 2021;7:eabh2944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8346217</ArticleId><ArticleId IdType="pubmed">34362739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>